NAS:SRTA (USA)
Â
Class A
$
6.02
-0.22 (-3.53%)
11:00 AM EST
Business Description
Strata Critical Medical Inc
NAICS : 621999
SIC : 8099
ISIN : US0926671043
Share Class Description:
SRTA: Class ATotal Employee Number:
601Description
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.35 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -1.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.37 | |||||
Beneish M-Score | -0.46 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.4 | |||||
3-Year EBITDA Growth Rate | 36.4 | |||||
3-Year EPS without NRI Growth Rate | 31.8 | |||||
3-Year FCF Growth Rate | -11.2 | |||||
3-Year Book Growth Rate | -5.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 76.46 | |||||
9-Day RSI | 70.27 | |||||
14-Day RSI | 65.93 | |||||
3-1 Month Momentum % | -11.03 | |||||
6-1 Month Momentum % | 14.67 | |||||
12-1 Month Momentum % | 21.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.64 | |||||
Quick Ratio | 2.64 | |||||
Cash Ratio | 0.5 | |||||
Days Sales Outstanding | 53.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.6 | |||||
Shareholder Yield % | 1.32 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 20.56 | |||||
Operating Margin % | -7.97 | |||||
Net Margin % | 15.71 | |||||
EBITDA Margin % | -1.61 | |||||
FCF Margin % | -19.34 | |||||
OCF Margin % | -14.08 | |||||
ROE % | 14.89 | |||||
ROA % | 12.74 | |||||
ROIC % | -8.89 | |||||
3-Year ROIIC % | 23.18 | |||||
ROC (Joel Greenblatt) % | -25.72 | |||||
ROCE % | -7.1 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 11.85 | |||||
Forward PE Ratio | 79.9 | |||||
Price-to-Owner-Earnings | 13.16 | |||||
PS Ratio | 2.03 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 4.74 | |||||
EV-to-EBIT | -25.19 | |||||
EV-to-EBITDA | -124.71 | |||||
EV-to-Revenue | 2.01 | |||||
EV-to-Forward-Revenue | 0.86 | |||||
EV-to-FCF | -10.38 | |||||
Price-to-GF-Value | 1.26 | |||||
| Price-to-Net-Current-Asset-Value | 7.92 | |||||
Earnings Yield (Greenblatt) % | -3.97 | |||||
FCF Yield % | -9.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SRTA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Strata Critical Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 255.975 | ||
| EPS (TTM) ($) | 0.508 | ||
| Beta | 3.3162 | ||
| 3-Year Sharpe Ratio | 0.3 | ||
| 3-Year Sortino Ratio | 0.54 | ||
| Volatility % | 47.53 | ||
| 14-Day RSI | 65.93 | ||
| 14-Day ATR ($) | 0.252137 | ||
| 20-Day SMA ($) | 5.656 | ||
| 12-1 Month Momentum % | 21.7 | ||
| 52-Week Range ($) | 3.85 - 6.5 | ||
| Shares Outstanding (Mil) | 88.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Strata Critical Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Strata Critical Medical Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-10 08:00 | In 79 days | ||
| Third quarter earnings results for 2026 | 2026-11-10 | In 78 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 08:00 | 5.55 (+9.90%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 5.55 (+9.90%) | ||
| General meeting for 2026 | 2026-05-28 09:00 | 6.26 (+1.79%) | ||
| First quarter earnings conference call for 2026 | 2026-05-06 08:00 | 4.82 (-2.63%) | ||
| First quarter earnings results for 2026 | 2026-05-06 | 4.82 (-2.63%) | ||
| 25th Annual Needham Virtual Healthcare Conference | 2026-04-15 13:30 | 4.33 (+4.59%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-03-03 08:00 | 4.49 (+6.90%) | ||
| Annual report for 2025 | 2026-03-03 | 4.49 (+6.90%) |
Show
Entries
Strata Critical Medical Inc Frequently Asked Questions
What is Strata Critical Medical Inc(SRTA)'s stock price today?
The current price of SRTA is $6.02. The 52 week high of SRTA is $6.50 and 52 week low is $3.85.
When is next earnings date of Strata Critical Medical Inc(SRTA)?
The next earnings date of Strata Critical Medical Inc(SRTA) is 2026-11-10 Est..
Does Strata Critical Medical Inc(SRTA) pay dividends? If so, how much?
Strata Critical Medical Inc(SRTA) does not pay dividend.
Guru Commentaries on NAS:SRTA
Constantcontact
Bullish
2026 Q2
84a2866d 8ed8 414e aeb1 57abfa9f74be
What the manager wrote
Strata Critical Medical is a high-quality logistics and services asset growing more than 20% organically while operating in an inefficient, fragmented industry. The company has a pristine balance sheet with zero debt and $59 million in cash, positioning it well for consolidation opportunities. Strata is benefiting from the unmet need for organs, which is driving significant changes in organ distribution rules and expanding the donor pool. With a projected 30% CAGR in EBITDA over the next five years, the current valuation appears too low, suggesting potential for substantial returns on investment.
Press Release
Articles on Strata Critical Medical Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers